Today, there are several important reports scheduled for release that could impact the market. While our robots have typically leaned towards market neutrality, they have recently started taking short positions. If I had to choose a robot for this week, I would select the Swing Trader Popular Stocks 4K per position Market Neutral Strategy, which tends to maintain market-neutral positions and has a track record of generating profits in any market condition.
ASML Holding N.V. (ASML)is reporting for the quarter ending March 31, 2023. The capital goods company's consensus earnings per share forecast from the 1 analyst that follows the stock is $4.59. This value represents a 27.86% increase compared to the same quarter last year. In the past year ASML and beat the expectations the other three quarters.
Abbott Laboratories (ABT)is reporting for the quarter ending March 31, 2023. The medical products company's consensus earnings per share forecast from the 9 analysts that follow the stock is $0.98. This value represents a 43.35% decrease compared to the same quarter last year. In the past year ABT has beat the expectations every quarter. The highest one was in the 4th calendar quarter where they beat the consensus by 14.44%.
Morgan Stanley (MS)is reporting for the quarter ending March 31, 2023. The investment bankers company's consensus earnings per share forecast from the 7 analysts that follow the stock is $1.67. This value represents a 18.93% decrease compared to the same quarter last year. MS missed the consensus earnings per share in the 2nd calendar quarter of 2022 by -7.1%.
Elevance Health, Inc. (ELV)is reporting for the quarter ending March 31, 2023. The medical services company's consensus earnings per share forecast from the 16 analysts that follow the stock is $9.30. This value represents a 12.73% increase compared to the same quarter last year. In the past year ELV has beat the expectations every quarter. The highest one was in the 4th calendar quarter where they beat the consensus by 0.58%.
U.S. Bancorp (USB)is reporting for the quarter ending March 31, 2023. The bank company's consensus earnings per share forecast from the 10 analysts that follow the stock is $1.13. This value represents a 14.14% increase compared to the same quarter last year. In the past year USB has beat the expectations every quarter. The highest one was in the 4th calendar quarter where they beat the consensus by 8.11%.
Nasdaq, Inc. (NDAQ) is set to report its earnings for the quarter ending March 31, 2023. The securities exchange company's consensus earnings per share forecast from the 9 analysts that follow the stock is $0.65, which is a 1.52% decrease compared to the same quarter last year. NDAQ missed the consensus earnings per share in the 4th calendar quarter of 2022 by -1.54%.
Citizens Financial Group, Inc. (CFG) is also reporting for the quarter ending March 31, 2023. The savings & loan company's consensus earnings per share forecast from the 8 analysts that follow the stock is $1.11, indicating a 3.74% increase compared to the same quarter last year. CFG missed the consensus earnings per share in the 4th calendar quarter of 2022 by -3.85%.
Synchrony Financial (SYF) is also set to report its earnings for the quarter ending March 31, 2023. The financial services company's consensus earnings per share forecast from the 13 analysts that follow the stock is $1.49, which represents a 13.87% decrease compared to the same quarter last year. However, in the past year, SYF has managed to beat expectations every quarter, with the highest beat being in the 4th calendar quarter, where they surpassed the consensus by 12.5%.
Ally Financial Inc. (ALLY) is reporting for the quarter ending March 31, 2023. The financial services company's consensus earnings per share forecast from the 8 analysts that follow the stock is $0.88, indicating a 56.65% decrease compared to the same quarter last year.
Lastly, Lithia Motors, Inc. (LAD) is reporting for the quarter ending March 31, 2023. The retail company's consensus earnings per share forecast from the 6 analysts that follow the stock is $8.77, which represents a 26.67% decrease compared to the same quarter last year.
MS saw its Momentum Indicator move above the 0 level on February 14, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 73 similar instances where the indicator turned positive. In of the 73 cases, the stock moved higher in the following days. The odds of a move higher are at .
MS moved above its 50-day moving average on January 15, 2025 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MS crossed bullishly above the 50-day moving average on January 21, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MS advanced for three days, in of 338 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 311 cases where MS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for MS moved out of overbought territory on February 07, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 39 similar instances where the indicator moved out of overbought territory. In of the 39 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 63 cases where MS's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for MS turned negative on February 10, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 40 similar instances when the indicator turned negative. In of the 40 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
MS broke above its upper Bollinger Band on February 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. MS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.694) is normal, around the industry mean (5.562). P/E Ratio (18.056) is within average values for comparable stocks, (34.442). Projected Growth (PEG Ratio) (3.334) is also within normal values, averaging (2.610). Dividend Yield (0.036) settles around the average of (0.030) among similar stocks. P/S Ratio (3.039) is also within normal values, averaging (113.078).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of diversified financial services including brokerage, investment management and venture capital services
Industry InvestmentBanksBrokers